Through the lens of BristolBMJ 1998; 316 doi: https://doi.org/10.1136/bmj.316.7149.0 (Published 27 June 1998) Cite this as: BMJ 1998;316:0
The Bristol case continues to reverberate (p 1924) and will, suggests Richard Smith in his opening editorial, for years to come (p 1917). For now, it provides a lens for the way we see the practice of medicine.
For example, one of the issues the General Medical Council identified as arising out of the case (p 1917) is how doctors communicate risks to patients. Yet, as John-Arne Skolbekken shows, communicating risk is tricky—to doctors, as well as patients (p 1956). He takes the data from the WOSCOPS and 4S trials of cholesterol reduction to …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial